Instalab
logoInstalab

Weight

The simplest number you can track, and one of the strongest predictors of how long you'll live.

Should you take a Weight test?

This test is most useful if any of these apply to you.

Healthy but Want to Stay Ahead
You feel fine and want a reliable baseline to catch any drift early, before standard labs start to shift.
Worried About Heart or Diabetes Risk
You have a family history of heart disease or diabetes and want to use weight trends as an early warning system.
Actively Trying to Lose Weight
You're on a structured diet, exercise, or medication plan and need an honest read on whether it's working week to week.
Told Your Blood Sugar Is Borderline
You've been flagged with prediabetes or insulin resistance and want to track the single behavior change that matters most for reversing it.

About Weight

The number on your scale is one of the most powerful predictors of how long you live and what diseases you develop. It is also one of the most misunderstood, because weight alone cannot tell you what is muscle, what is fat, and where that fat is sitting on your body.

That said, tracked over time and read in context, your weight is a remarkably honest signal of energy balance, metabolic strain, and disease risk. The goal of this guide is to help you read that signal with the same precision a longevity-focused physician would.

What Weight Actually Reflects

Body weight is not a single molecule. It is the integrated sum of fat tissue, muscle, bone, and water, governed by a feedback loop between your appetite hormones and your brain. Hormones from fat (leptin), the stomach (ghrelin), the pancreas (insulin), and the gut (GLP-1, PYY) all report to your brain, which then adjusts hunger and energy use to defend a set point.

When intake exceeds expenditure over months and years, fat tissue grows, and so does the chronic, low-grade inflammation it produces. When intake falls well below expenditure, the same system flips into starvation mode, slowing metabolism and raising appetite. This is why weight is so hard to move and so meaningful when it does.

Heart Attack, Stroke, and Heart Failure

Weight, expressed as BMI (body mass index, your weight divided by your height squared), tracks closely with the leading killers of adults. A pooled analysis of 97 prospective studies including 1.8 million people found that each 5 kg/m² of higher BMI raised the risk of coronary heart disease by about 27% and stroke by about 18%. Roughly half of the heart disease risk and three-quarters of the stroke risk traveled through blood pressure, serum cholesterol, and blood sugar, meaning weight does most of its cardiovascular damage by pushing these other numbers in the wrong direction.

The signal is even stronger for heart failure and atrial fibrillation. In a large multi-cohort study of nearly 290,000 adults followed for a median of about 19 years, people with class 2 obesity had about twice the risk of heart failure and substantially higher risk of atrial fibrillation compared to normal weight, with risks rising further in class 3 obesity.

Type 2 Diabetes

Weight has a tighter relationship with diabetes than almost any other modifiable factor. A meta-analysis of 216 studies covering tens of millions of adults found that each 5 kg/m² rise in BMI raised type 2 diabetes risk by about 72%. Pooling 84 studies showed that, compared to normal weight, overweight roughly doubled the risk, obesity raised it about fivefold, and severe obesity raised it many-fold higher.

What this means for you: even small, sustained weight changes shift this curve. Modest losses of 5% to 7% of body weight cut the risk of progressing from prediabetes to diabetes by more than half in randomized trials.

Cancer

Excess weight is now linked with strong evidence to at least nine cancers, including esophageal, colon, pancreatic, kidney, endometrial, and biliary tract. In the largest umbrella review of these associations, each 5 kg/m² of higher BMI raised risk by roughly 9% for rectal cancer in men up to about 56% for biliary tract cancer. Large prospective cohorts have shown that adults with severe obesity (BMI 40 or higher) have substantially higher cancer mortality than those at normal weight, with relative increases above 50% in some analyses.

All-Cause Mortality

The largest mortality analysis ever conducted, pooling 239 studies and 10.6 million adults, found that healthy never-smokers had the lowest risk of death across a BMI range of roughly 20.0 to 25.0, with the exact nadir shifting by age (closer to BMI 22 in younger adults and closer to BMI 24 in older adults). Above 25, each 5 kg/m² of higher BMI raised the risk of dying from any cause by about 39% in European populations and 29% in North American populations. The same study found the effect was stronger in younger adults: at ages 35 to 49, each 5-unit increase raised mortality risk by about 52%, compared with 21% at ages 70 to 89.

What this means for you: the earlier in life your weight starts drifting upward, the more years of compounding risk you are taking on. A 35-year-old with rising weight has more at stake than a 70-year-old with the same number on the scale.

Why Weight Alone Can Mislead You

Two people can weigh the same and have very different health risks. About half of the people with excess body fat are not flagged as obese using BMI alone, and roughly 20% or more of normal-weight adults are metabolically unhealthy, meaning their blood sugar, lipids, and blood pressure look like someone with obesity. The prevalence varies substantially by ancestry, with higher rates reported in South and East Asian populations. These individuals have at least twice the risk of heart attack compared to metabolically healthy normal-weight peers, with some analyses showing an even larger gap.

This is the central paradox of weight: a normal scale reading is not a clean bill of health, and an elevated scale reading does not always mean metabolic disease. Weight is most useful when paired with waist circumference (a proxy for visceral fat), body composition (which separates muscle from fat), and standard metabolic labs. The reading you should pay closest attention to is your own trend, not a single number against a population chart.

Reconciling the Obesity Paradox

You may have read that overweight people sometimes live longer than normal-weight people with the same disease, especially heart failure. This is real in some datasets, but it is largely explained by two things. First, fitness matters more than weight for survival, and many of the longer-lived overweight individuals in these studies were also more active. Second, the comparison group of "normal-weight" patients often includes people who lost weight because they were sick, not because they were healthy.

Randomized and large observational studies of intentional weight loss in people with obesity show reduced mortality, not increased mortality. The takeaway is not that gaining weight is protective. It is that fitness, muscle mass, and the reason for weight change matter as much as the weight itself.

Why a Single Reading Is Not Enough

Body weight fluctuates by 1 to 3 kg over a single day from food, fluids, sodium, glycogen stores, and bowel movements. A single morning reading after a salty dinner can look alarming and mean nothing. The value of weight comes from the trajectory, not the snapshot.

Weigh yourself under consistent conditions: same time of day (first thing in the morning is best), same clothing, after using the bathroom, before eating or drinking. Then look at the rolling average across 7 to 14 days rather than reacting to any individual number. A trend that climbs 2 to 3 kg over a few months is a real signal. A 1 kg jump from yesterday is noise.

For active health management, weigh in 3 to 7 times per week and track the moving average. If you are working to change your weight, expect the trend to move at roughly 0.25 to 1 kg per week. Slower than that and the intervention is not strong enough. Faster than that and you may be losing muscle and water rather than fat.

When the Scale Misleads You

  • Hydration and sodium: a salty meal, hard workout, or alcohol the night before can shift the number by 1 to 2 kg without any change in body fat.
  • Recent intense exercise: strenuous training can cause acute muscle swelling and water retention for 24 to 72 hours, masking real fat loss on the scale.
  • Menstrual cycle: water retention in the second half of the cycle can add 1 to 3 kg that disappears within days.
  • Glycogen and carb intake: each gram of stored carbohydrate holds roughly 3 grams of water (estimates in the literature range from about 2.7 to 4 grams), which is why low-carb diets cause large early drops that are not fat loss.

Medications That Move the Number

Several common prescriptions shift weight as a side effect. On the gain side: corticosteroids, insulin, sulfonylureas, pioglitazone, gabapentin, amitriptyline, mirtazapine, and atypical antipsychotics like olanzapine and quetiapine can add 1 to 5 kg or more. Statins cause a small average gain of about 0.24 to 0.33 kg over four years, which is clinically minor. On the loss side: metformin, GLP-1 agonists, SGLT-2 inhibitors, topiramate, and bupropion all push weight down.

If you started a new medication around the time your weight began drifting, it deserves a conversation with your prescriber before you assume the drift is about diet or activity.

What to Do With an Unexpected Trend

If your weight is trending up by more than 2 kg over 3 months despite no obvious behavioral changes, do not wait for a doctor's visit to start investigating. Get a fasting metabolic workup that includes glucose, HbA1c, fasting insulin, a lipid panel with ApoB, a comprehensive metabolic panel for liver and kidney function, and TSH for thyroid status. Pair the weight with a waist circumference measurement (above 102 cm in men or 88 cm in women is elevated; for Asian ancestry, those thresholds drop to roughly 90 cm and 80 cm).

If your weight is trending down without intentional effort, the workup matters even more. Unexplained weight loss of 5% or more over 6 to 12 months can be an early sign of thyroid disease, diabetes, gastrointestinal disorders, or, less commonly, cancer. The combination of weight loss with elevated inflammation markers, anemia, or abnormal liver enzymes is a signal to escalate to a physician quickly rather than wait.

For anyone managing weight actively, a DEXA scan once or twice a year is the cleanest way to confirm that the loss on the scale is fat rather than muscle. A combined picture of weight, waist circumference, body composition, and metabolic labs is what turns a single number into a decision.

What Moves This Biomarker

Evidence-backed interventions that affect your Weight level

Decrease
Tirzepatide (weekly injection)
Tirzepatide produced roughly 21% body weight loss at 72 weeks at the highest dose, the largest effect of any approved weight medication and a level that approaches what some bariatric surgeries achieve. This dual GIP/GLP-1 agonist works by reducing appetite and slowing how quickly your stomach empties.
MedicationStrong Evidence
Decrease
Semaglutide 2.4 mg weekly
Semaglutide produced about 11% to 15% body weight loss in pivotal trials and network meta-analyses of weight medications. As a GLP-1 receptor agonist, it lowers appetite and slows gastric emptying, with sustained effects as long as you continue the medication.
MedicationStrong Evidence
Decrease
Phentermine-topiramate (15/92 mg daily)
This combination pill produced about 10 kg (roughly 10% body weight) loss versus a small loss with placebo at 56 weeks. It was ranked among the most effective oral weight medications alongside GLP-1 agonists in a large network meta-analysis.
MedicationStrong Evidence
Decrease
Liraglutide 3.0 mg daily
Liraglutide produced about 8 kg (roughly 8%) body weight loss compared to less than 3 kg with placebo at 56 weeks. As a daily GLP-1 injection, it is an older relative of semaglutide with a similar but smaller effect.
MedicationStrong Evidence
Decrease
Intensive lifestyle intervention with 500 to 750 kcal/day energy deficit
A structured calorie deficit (typically 1,200 to 1,500 kcal/day for women and 1,500 to 1,800 for men) produced 5% to 10% body weight loss at 12 to 24 months. In the Look AHEAD trial of more than 5,000 adults with type 2 diabetes, a substantial share maintained at least 5% loss over many years of follow-up.
DietStrong Evidence
Decrease
Orlistat 120 mg three times daily
Orlistat produced roughly 3 kg of additional weight loss versus placebo at one year by blocking dietary fat absorption in the gut. Gastrointestinal side effects are common and dose-related.
MedicationModerate Evidence
Decrease
Naltrexone-bupropion (32/360 mg)
This combination produced about 6 kg of weight loss versus roughly 1 kg with placebo at 56 weeks by acting on appetite and reward pathways in the brain.
MedicationModerate Evidence
Decrease
Low-carbohydrate or low-fat diet
In a network meta-analysis, both low-carbohydrate and low-fat diets produced approximately 8 kg loss at 6 months and about 7 kg at 12 months compared to no dietary intervention, with minimal differences between macronutrient strategies. What matters most is the calorie deficit and your ability to stick with it.
DietModerate Evidence
Decrease
Aerobic exercise 150 to 300 minutes per week
Aerobic exercise produces dose-dependent weight loss in adults with overweight or obesity, with roughly a few kilograms more loss at higher weekly volumes. Exercise alone produces modest loss, but it preserves muscle and dramatically improves cardiovascular fitness and metabolic health beyond what the scale shows.
ExerciseModerate Evidence
Decrease
Resistance training combined with caloric restriction
In a trial of obese older adults, resistance training combined with diet produced roughly 9 kg loss at 6 months while preserving more lean mass than aerobic training alone. For body composition, resistance training is the most important addition because the scale falls more slowly but the loss is almost entirely fat.
ExerciseModerate Evidence
Increase
Corticosteroids (long-term)
Long-term corticosteroid use causes significant weight gain by increasing appetite and shifting fat distribution toward the abdomen. If you must take these for an autoimmune or inflammatory condition, the weight gain is a real biological effect, not just water retention, and tends to persist as long as you remain on therapy.
MedicationModerate Evidence
Increase
Atypical antipsychotics (olanzapine, quetiapine, risperidone)
Atypical antipsychotics cause clinically meaningful weight gain (olanzapine roughly +2 to 3 kg, with smaller gains from quetiapine and risperidone in pooled trials) by altering appetite signaling. The gain raises cardiometabolic risk and is a known reason to monitor weight, glucose, and lipids when starting these medications.
MedicationModerate Evidence
Increase
Insulin therapy
Insulin therapy can cause several kilograms of weight gain when initiated, partly because it pushes glucose into fat cells and partly because tighter glycemic control reduces the calorie loss that comes from spilling glucose into urine. The gain is real but does not mean insulin is the wrong choice; it means weight should be co-managed.
MedicationModerate Evidence
Increase
Sulfonylureas and pioglitazone
Sulfonylureas and pioglitazone each add roughly 2 to 3 kg over months to years in diabetes trials. These medications work, but in the era of GLP-1 agonists and SGLT-2 inhibitors, the weight gain side effect is increasingly avoidable by choosing weight-neutral or weight-losing alternatives.
MedicationModerate Evidence
Increase
Gabapentin, amitriptyline, mirtazapine
These commonly prescribed neurologic and psychiatric medications add roughly 1 to 2 kg on average. If you are gaining weight without a clear cause and take one of these, the medication is a likely contributor and a substitution conversation with your prescriber is warranted.
MedicationModest Evidence
Decrease
Metformin
Metformin produces about 1 to 2 kg of weight loss per year and modest sustained weight reduction over long-term follow-up in the Diabetes Prevention Program. The effect is small per year but accumulates, and metformin remains a useful first-line option for people with insulin resistance because it pushes weight in the right direction.
MedicationModest Evidence
Decrease
Psyllium fiber
Psyllium produced about 3.7 kg of weight loss in a network meta-analysis of supplement trials, the largest effect among supplements with moderate-certainty evidence. It works by adding bulk and slowing digestion, which reduces calorie intake.
SupplementModest Evidence
Decrease
Glucomannan
Glucomannan, a soluble fiber, produced roughly 1 to 1.5 kg of weight loss in pooled trials. The effect is small but consistent across studies, with low to moderate certainty of evidence.
SupplementModest Evidence
Decrease
Green tea extract
Green tea extract produced about 1.25 kg of weight loss in a meta-analysis, with low certainty of evidence. The effect is real but small enough that it should be considered a minor contributor rather than a primary strategy.
SupplementModest Evidence

Frequently Asked Questions